CATECHOLAMINES AND THYROTOXICOSIS DIMINUTION OF DOPAMINE BETA HYDROXYLASE IN HYPERTHYROIDISM

dc.contributor.authorZIMBRON
dc.contributor.authorSERRANO
dc.contributor.authorGOLDSTEIN
dc.contributor.authorFREEMAN, GUSTAVE
dc.contributor.authorCHAVEZ LARA
dc.contributor.authorCHAVEZ DOMINGUEZ, R
dc.date.accessioned2026-05-28T16:38:09Z
dc.date.issued1974
dc.description.paginacion309 - 315
dc.description.procedenciaLOC
dc.format.discursoArtículo
dc.format.extent7
dc.identifier.issn0034-8376
dc.identifier.urihttps://ahcm.cinvestav.mx/handle/ahcm/25263
dc.language.isoEspañol
dc.numero.secuencia25260
dc.publisherINST NACL CARDIOL,MEXICO CITY 7,MEXICO
dc.publisherNYU,MED CTR,NEW YORK,NY
dc.publisherLABS CLIN MEXICO,MEXICO CITY,MEXICO
dc.relation.ispartofseriesVol. 26 No. 4
dc.source.revistafuenteREVISTA DE INVESTIGACION CLINICA
dc.subjectCATECHOLAMINES, THYROTOXICOSIS, DOPAMINE BETA HYDROXYLASE, HYPERTHYROIDISM
dc.subject.categoriaprincipalCIENCIAS MEDICAS
dc.subject.disciplinaCIENCIAS CLINICAS
dc.subject.subdisciplinaGENETICA CLINICA
dc.titleCATECHOLAMINES AND THYROTOXICOSIS DIMINUTION OF DOPAMINE BETA HYDROXYLASE IN HYPERTHYROIDISM
dc.title.alternativeREV INVEST CLIN

Files